October 15, 2025

Lessons from Van Gogh for the Next Decade of Launch

From insight to foresight: seeing enough, soon enough, to change course while there’s still enough time for it to matter.

In Amsterdam this October, leaders gathered at Pharmageddon Europe to roll up their sleeves and tackle the hard questions: What disruptors are hiding beneath the surface? Which structural blind spots have we tolerated too long? How can we surface early warning signs before it’s too late?

At our From Insight to Foresight: The Future of Launch experience, we built a gallery of ideas that looked beyond today’s capabilities to provoke what’s possible tomorrow. In life science, the teams that succeed won’t be the ones with the most data—they’ll be the ones who recognize the pattern first.

The heart of the experience was an interactive journey that brought this idea to life. You can now explore these stations for yourself:

Station 1: The Art of Collaboration: From Brushstroke to Pattern

Our first interactive experience invited participants to trace how a single advisory-board comment ripples outward into a repeating market insight. 

Step inside the experience.

That “first brushstroke” becomes meaningful only when overlaid with signals from congress, field interactions, and social conversations. That’s where Launch Intelligence™ lives: layering human insight and intelligent signal detection until a pattern emerges.

A real-world launch example brought this concept to life. A GI launch team connected disparate voices across advisory boards, congress sessions, and digital channels to uncover a blind spot: patients with anxiety who were delaying diagnostic procedures. They pivoted quickly, broadening education to include mental-health professionals, equipping GI clinicians to address both psychological and physical needs, and reorienting field efforts for earlier diagnostic workups. The result was a course correction made while there was still time.

Station 2: Starry Night Meets Market Precision

Arguably Van Gogh’s most famous masterpiece, Starry Night captures the tension between his troubled state of mind and his desire to find order and beauty in the world around him. Said differently: even in chaos, there’s a pattern. Our second interactive layer does the same for market signals. 

Experience it in motion.

Even in complex, chaotic markets, structure is present. Launch Intelligence™ connects data from clinical conversations to behavioral trends and field feedback, turning noise into insight. The question shifts: not “What happened?” but “What’s forming?”

Station 3: Beyond the Horizon: The 2030 Launch Landscape

The third experience invited attendees to look ahead and imagine what AI-enabled foresight could mean for launches. 

Take a look ahead.

By 2030, AI will become more than a tool. It will be a partner capable of simulating scenarios, surfacing hidden risks, projecting outcomes, and recommending interventions before market disruption sets in. Teams won’t just respond to change; they’ll lead it.

Pattern Recognition: The New Competitive Edge

Van Gogh’s story offers more than metaphor; it offers strategic lessons. Tools and feedback shape trajectory. Readiness determines whether your work finds its audience. And support, or the lack of it, can determine whether vision endures or fades. In launch, missing early signals can cost more than market share—it can cost the launch itself.

We designed the Pharmageddon gallery to challenge how life science teams think about readiness. Most teams measure readiness by execution—content, metrics, and field plans—but the next frontier is interpretation: connecting signals, detecting emerging patterns, and acting while there’s still room to change.

Every second counts. The race to launch is unforgiving, and second place can mean billions in lost market share.

Pattern recognition is the new competitive advantage.

Launch Intelligence™ doesn’t replace intuition; it amplifies it. When the full picture comes into focus, ambiguity gives way to clarity, and clarity is the difference between launching on time or watching competitors reach the market first. By the time dashboards flash a warning, it’s already too late. The most successful teams don’t wait for lagging indicators, they act on foresight, not hindsight.

Launch Intelligence™ helps you see the hidden currents, the subtle shifts, and the friction points no one else sees — so you can steer while the course is still yours to choose.

See the Whole Picture

You only launch once. The window to adapt is short, but the opportunity to lead is enormous.

If you’re ready to see what’s really happening in your market, and act before opportunity slips away, explore how Launch Intelligence™ turns fragmented signals into clarity, foresight, and confident action.

Request a demo to experience Launch Intelligence™ in action.

Then, go deeper with our latest ebook: Failure to Launch: Navigating Today’s Market with Launch Intelligence™.
It’s a behind-the-scenes look at why so many pharma launches miss their mark and how leaders are using real-time intelligence to reverse the trend.

Related Posts:

Life science insight

What is the value of transformation?

Going 100% virtual changed everything about how life science companies gather insights to fuel their critical work.
How medical affairs and commercial teams can work together

Pharma launch excellence: How medical affairs and commercialization teams can win together

Unify medical and commercial teams to accelerate launch success
patient-centricity

The power of patient voices: how to strengthen patient-centricity

Patients want to be heard – here’s how life science teams can be better listeners.